Loading…

Branched-chain amino acid-enriched nutrients improve nutritional and metabolic abnormalities in the early post-transplant period after living donor liver transplantation

Background/purpose Malnutrition and metabolic disorder of patients undergoing living donor liver transplantation (LDLT) can affect post-transplant prognosis. The aim of this study was to establish whether perioperative usage of branched-chain amino-acid (BCAA)-enriched nutrients improve metabolic ab...

Full description

Saved in:
Bibliographic Details
Published in:Journal of hepato-biliary-pancreatic sciences 2012-07, Vol.19 (4), p.438-448
Main Authors: Yoshida, Ryuichi, Yagi, Takahito, Sadamori, Hiroshi, Matsuda, Hiroaki, Shinoura, Susumu, Umeda, Yuzo, Sato, Daisuke, Utsumi, Masashi, Nagasaka, Takeshi, Okazaki, Nami, Date, Ai, Noguchi, Ayako, Tanaka, Akemi, Hasegawa, Yuko, Sakamoto, Yachiyo, Fujiwara, Toshiyoshi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background/purpose Malnutrition and metabolic disorder of patients undergoing living donor liver transplantation (LDLT) can affect post-transplant prognosis. The aim of this study was to establish whether perioperative usage of branched-chain amino-acid (BCAA)-enriched nutrients improve metabolic abnormalities of patients undergoing LDLT. Methods We designed a randomized pilot study (UMIN registration number; 000004323). Twenty-five consecutive adult elective LDLT recipients were enroled and divided into two groups: the BCAA group (BCAA-enriched nutrients, n  = 12) and the control group (standard diet, n  = 13). Metabolic and nutritional parameters, including BCAA-to-tyrosine ratio (BTR), retinol binding protein (RBP), and prealbumin were regularly measured from 1 week before to 4 weeks after LDLT. Non-protein respiratory quotient (npRQ) was measured before and 4 weeks after LDLT. Results BTR and RBP improved considerably in the BCAA group compared with the controls. npRQ significantly increased from 1 week before LDLT to 4 weeks after LDLT in the BCAA group (0.77 ± 0.05 to 0.84 ± 0.06, P  = 0.002), but not in the control group (0.78 ± 0.04 to 0.81 ± 0.05). Conclusions Supplementation with BCAA-enriched nutrients might improve persistent nutritional and metabolic disorders associated with end-stage liver disease in the early post-transplant period, and consequently shorten the post-transplant catabolic phase after LDLT. A larger multicenter trial is needed to confirm these findings.
ISSN:1868-6974
1868-6982
DOI:10.1007/s00534-011-0459-5